🇺🇸 FDA
Patent

US 10406157

Tetrahydropyridopyrazine modulators of GPR6

granted A61KA61K31/4985A61K45/06

Quick answer

US patent 10406157 (Tetrahydropyridopyrazine modulators of GPR6) held by Takeda Pharmaceutical Company Limited expires Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Sep 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K31/4985, A61K45/06, A61P, A61P25/16